Michel Janssens

1.6k total citations
32 papers, 973 citations indexed

About

Michel Janssens is a scholar working on Epidemiology, Immunology and Virology. According to data from OpenAlex, Michel Janssens has authored 32 papers receiving a total of 973 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 17 papers in Immunology and 10 papers in Virology. Recurrent topics in Michel Janssens's work include HIV Research and Treatment (10 papers), Immunotherapy and Immune Responses (8 papers) and Immune Cell Function and Interaction (7 papers). Michel Janssens is often cited by papers focused on HIV Research and Treatment (10 papers), Immunotherapy and Immune Responses (8 papers) and Immune Cell Function and Interaction (7 papers). Michel Janssens collaborates with scholars based in Belgium, United States and Germany. Michel Janssens's co-authors include Geert Leroux‐Roels, Philippe Moris, Frédéric Clément, Nathalie Garçon, Marguerite Koutsoukos, Pierre Vandepapelière, Martine Wettendorff, Marcelle Van Mechelen, Pascale Van Belle and Yves Horsmans and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Journal of Virology.

In The Last Decade

Michel Janssens

30 papers receiving 948 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michel Janssens Belgium	16	463	364	284	234	146	32	973
W Keitel United States	18	318 0.7×	744 2.0×	309 1.1×	265 1.1×	142 1.0×	28	1.2k
Robert Paris United States	19	435 0.9×	334 0.9×	432 1.5×	228 1.0×	154 1.1×	61	1.3k
Elizabeth Clutterbuck United Kingdom	19	496 1.1×	865 2.4×	300 1.1×	178 0.8×	92 0.6×	46	1.4k
Gowrisankar Rajam United States	15	315 0.7×	550 1.5×	207 0.7×	227 1.0×	164 1.1×	30	1.0k
Linda Fritts United States	19	423 0.9×	360 1.0×	321 1.1×	115 0.5×	120 0.8×	33	957
Mary Allen United States	19	220 0.5×	220 0.6×	312 1.1×	198 0.8×	130 0.9×	57	1.1k
Lars R. Haaheim Norway	23	639 1.4×	979 2.7×	359 1.3×	264 1.1×	61 0.4×	59	1.5k
Victor H. Ferreira Canada	20	367 0.8×	437 1.2×	546 1.9×	127 0.5×	66 0.5×	59	1.3k
Edith Jasny Germany	13	412 0.9×	193 0.5×	536 1.9×	406 1.7×	70 0.5×	20	1.1k
Annelies W. Mesman United States	15	302 0.7×	452 1.2×	395 1.4×	137 0.6×	47 0.3×	24	873

Countries citing papers authored by Michel Janssens

Since Specialization

Citations

This map shows the geographic impact of Michel Janssens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Janssens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Janssens more than expected).

Fields of papers citing papers by Michel Janssens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Janssens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Janssens. The network helps show where Michel Janssens may publish in the future.

Co-authorship network of co-authors of Michel Janssens

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Janssens. A scholar is included among the top collaborators of Michel Janssens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Janssens. Michel Janssens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Janssens, Michel, et al.. (2024). Direct voxel classification from x-ray projections for 3D pore detection applied to laser sintered parts. Measurement Science and Technology. 35(4). 46004–46004. 2 indexed citations

Alsdurf, Hannah, Vanesa Bol, Nathalie De Schrevel, et al.. (2024). Establishing Correlates of Maternal-Fetal Cytomegalovirus Transmission—One Step Closer Through Predictive Modeling. The Journal of Infectious Diseases. 230(6). e1274–e1286. 1 indexed citations

Leroux‐Roels, Geert, Bruno Salaun, Michel Janssens, et al.. (2023). Proficiency tests to evaluate the impact on assay outcomes of harmonized influenza-specific Intracellular Cytokine Staining (ICS) and IFN-ɣ Enzyme-Linked ImmunoSpot (ELISpot) protocols. Journal of Immunological Methods. 523. 113584–113584. 4 indexed citations

Salaun, Bruno, Jonathan De Smedt, Charlotte Vernhes, et al.. (2023). T cells, more than antibodies, may prevent symptoms developing from respiratory syncytial virus infections in older adults. Frontiers in Immunology. 14. 1260146–1260146. 5 indexed citations

Janssens, Michel, et al.. (2022). Deep learning based sinogram interpolation applied to X-ray CT measurements of polymer additive manufacturing parts. e-Journal of Nondestructive Testing. 27(3).

Buricchi, Francesca, Patricia Bourguignon, Ugo D’Oro, et al.. (2021). Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants. npj Vaccines. 6(1). 78–78. 34 indexed citations

Meeren, Olivier Van Der, Erik Jongert, Kelly E. Seaton, et al.. (2020). Persistence of vaccine-elicited immune response up to 14 years post-HIV gp120-NefTat/AS01B vaccination. Vaccine. 38(7). 1678–1689. 3 indexed citations

Cicconi, Paola, Claerwen M. Jones, Laura Silva-Reyes, et al.. (2019). First-in-human randomized study to assess the safety and immunogenicity of an investigational respiratory syncytial virus (RSV) vaccine based on ChAd155 viral vector expressing RSV viral proteins F, N and M2-1 in healthy adults.. Clinical Infectious Diseases. 4 indexed citations

Cicconi, Paola, Claire Jones, Laura Silva-Reyes, et al.. (2019). First-in-Human Randomized Study to Assess the Safety and Immunogenicity of an Investigational Respiratory Syncytial Virus (RSV) Vaccine Based on Chimpanzee-Adenovirus-155 Viral Vector–Expressing RSV Fusion, Nucleocapsid, and Antitermination Viral Proteins in Healthy Adults. Clinical Infectious Diseases. 70(10). 2073–2081. 43 indexed citations

10.

Chaud, P., S Haeghebaert, Geneviève Leduc, et al.. (2017). Infectious disease surveillance of migrant populations in Calais and Grande-Synthe, France, November 2015-October 2016.. 374–381. 2 indexed citations

11.

Burny, Wivine, Andrea Callegaro, Viviane Bechtold, et al.. (2017). Different Adjuvants Induce Common Innate Pathways That Are Associated with Enhanced Adaptive Responses against a Model Antigen in Humans. Frontiers in Immunology. 8. 943–943. 101 indexed citations

12.

Kuehne, Anna, Amanda Tiffany, Estrella Lasry, et al.. (2016). Impact and Lessons Learned from Mass Drug Administrations of Malaria Chemoprevention during the Ebola Outbreak in Monrovia, Liberia, 2014. PLoS ONE. 11(8). e0161311–e0161311. 22 indexed citations

13.

Janssens, Michel, et al.. (2015). Ebola : chronique d’une catastrophe annoncée. Table ronde organisée le 12 février 2015 et animée par Paul Benkimoun. 12–31.

14.

Bourguignon, Patricia, Frédéric Clément, Marguerite Koutsoukos, et al.. (2014). Processing of blood samples influences PBMC viability and outcome of cell-mediated immune responses in antiretroviral therapy-naïve HIV-1-infected patients. Journal of Immunological Methods. 414. 1–10. 17 indexed citations

15.

Montoya, Jaime, Juan Antonio Solon, Luz P. Acosta, et al.. (2013). A Randomized, Controlled Dose-Finding Phase II Study of the M72/AS01 Candidate Tuberculosis Vaccine in Healthy PPD-Positive Adults. Journal of Clinical Immunology. 33(8). 1360–1375. 64 indexed citations

16.

Harrer, Thomas, Andreas Plettenberg, Keikawus Arastéh, et al.. (2013). Safety and immunogenicity of an adjuvanted protein therapeutic HIV-1 vaccine in subjects with HIV-1 infection: A randomised placebo-controlled study. Vaccine. 32(22). 2657–2665. 15 indexed citations

17.

Lumsden, Joanne M., Robert Schwenk, Lisa Rein, et al.. (2011). Protective Immunity Induced with the RTS,S/AS Vaccine Is Associated with IL-2 and TNF-α Producing Effector and Central Memory CD4+ T Cells. PLoS ONE. 6(7). e20775–e20775. 68 indexed citations

18.

Olotu, Ally, Philippe Moris, Jedidah Mwacharo, et al.. (2011). Circumsporozoite-Specific T Cell Responses in Children Vaccinated with RTS,S/AS01E and Protection against P falciparum Clinical Malaria. PLoS ONE. 6(10). e25786–e25786. 72 indexed citations

19.

Vandepapelière, Pierre, Yves Horsmans, Philippe Moris, et al.. (2008). Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers. Vaccine. 26(10). 1375–1386. 168 indexed citations

20.

Segura, Iris, Michel Janssens, Y. Cleuter, et al.. (1999). Human Immunodeficiency Virus Type 2 Produces a Defect in CD3-γ Gene Transcripts Similar to That Observed for Human Immunodeficiency Virus Type 1. Journal of Virology. 73(6). 5207–5213. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact